Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Elevated circulating luteinizing hormone level, Elevated circulating follicle stimulating hormone level, Decreased serum estradiol, and Primary amenorrhea.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 2 | Elevated circulating luteinizing hormone level, Elevated circulating follicle stimulating hormone level |
GDF9 encodes growth differentiation factor 9 (454 aa). Required for ovarian folliculogenesis. Promotes primordial follicle development. Stimulates granulosa cell proliferation. Highest expression in Testis (16.9 TPM) and Pituitary (2.6 TPM).
Premature ovarian failure 14 is associated with mutations in the GDF9 gene on chromosome 5.
GDF9 is classified as a druggable target (Druggable Genome, Growth Factor, and Transcription Factor categories) with score 1.1.
Genetic testing for GDF9 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for premature ovarian failure 14 has been reported in the published literature.
Phenotype severity distribution: 4 always present features.
No clinical trials have been registered for premature ovarian failure 14.
197 publications have been identified in PubMed for premature ovarian failure 14. Research spans Basic Science / Preclinical (35%), Review / Meta-Analysis (34%), and Epidemiology / Natural History (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 69 | 35% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:11 PM UTC
Online Mendelian Inheritance in Man
Hormones |
1 |
Primary amenorrhea |
Research summaries
67 |
34% |
Disease patterns and progression | 39 | 20% |
New treatment approaches | 8 | 4% |
Clinical study results | 7 | 4% |
Testing and diagnosis research | 3 | 2% |
Patient case studies | 3 | 2% |
Other research | 1 | 1% |
Quesada JA (2026). [PMID: 41529134](https://pubmed.ncbi.nlm.nih.gov/41529134/). *Menopause*. [Epidemiology / Natural History]
Chen JH (2026). [PMID: 41640848](https://pubmed.ncbi.nlm.nih.gov/41640848/). *Front Public Health*. [Clinical Trial Publication]
Gong LY (2026). [PMID: 41814824](https://pubmed.ncbi.nlm.nih.gov/41814824/). *Zhongguo Zhong Yao Za Zhi*. [Basic Science / Preclinical]
Li M (2026). [PMID: 41934138](https://pubmed.ncbi.nlm.nih.gov/41934138/). *BJOG*. [Epidemiology / Natural History]
TanTai W (2026). [PMID: 41498691](https://pubmed.ncbi.nlm.nih.gov/41498691/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
Jin J (2026). [PMID: 41503791](https://pubmed.ncbi.nlm.nih.gov/41503791/). *Gut Microbes*. [Epidemiology / Natural History]
Ozcakar TG (2026). [PMID: 42349090](https://pubmed.ncbi.nlm.nih.gov/42349090/). *Eur J Obstet Gynecol Reprod Biol*. [Basic Science / Preclinical]
Huang Z (2026). [PMID: 42311506](https://pubmed.ncbi.nlm.nih.gov/42311506/). *Front Cell Dev Biol*. [Review / Meta-Analysis]
Ling C (2026). [PMID: 41795290](https://pubmed.ncbi.nlm.nih.gov/41795290/). *Phytomedicine*. [Basic Science / Preclinical]
Gu H (2026). [PMID: 41270827](https://pubmed.ncbi.nlm.nih.gov/41270827/). *J Genet Genomics*. [Review / Meta-Analysis]
AI-curated news mentioning premature ovarian failure 14
Updated Aug 17, 2026
A study published in PubMed examines the sexual function of patients with Turner syndrome compared to women with premature ovarian insufficiency. The findings contribute to understanding the unique challenges faced by these patient populations.